177 / 490
175
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
POSTERS
> Hydrogel injection prevents long-term rectal toxicity after radiotherapy
for prostate cancer
M. Pinkawa (Germany), V. Schmitt, V. Djukic, J. Klotz, L. König, D. Frank,
B. Krenkel, M. Eble
PO-0738
> IMRT versus 3D conformal radiotherapy when used in combination
with I-125 prostate brachytherapy
A. Yorozu (Japan), T. Tanaka, R. Kota, Y. Takagawa, Y. Shiraishi, K. Toya,
S. Saito
PO-0739
> Nodal clearance rate and efficacy of individualised SN-based pelvic
IMRT for prostate cancer
A. Müller (Germany), F. Eckert, F. Paulsen, D. Zips, A. Stenzl, D. Schilling,
M. Alber, R. Bares, P. Martus, D. Weckermann, C. Belka, U. Ganswindt
PO-0740
> Even high-dose radiotherapy requires long-term androgen ablation for
high-risk prostate cancer
T.K. Nam (Republic of Korea), D.D. Kwon, J.W. Jeong, Y.H. Kim,
M.S. Yoon, J.Y. Song, S.J. Ahn, W.K. Chung
PO-0741
> Image-guided IMRT reduces late toxicity compared to 3D-CRT for
prostate cancer
R. Wortel (The Netherlands), L. Incrocci, F. Pos, U. Van der Heide,
J. Lebesque, S. Aluwini, M. Witte, W. Heemsbergen
PO-0742
> Stereotactic body radiotherapy in recurrent lymph nodes metastases
from prostate cancer
F. Trippa (Italy), E. Maranzano, E. Ponti, A. Carosi, F. Arcidiacono,
L. Draghini, L. Di Murro, A. Lancia, P. Anselmo, R. Santoni, G. Ingrosso
PO-0743
> Effects of IMRT or radical prostatectomy (RP) on serum testosterone in
patients with prostate cancer
A. Giraldo Marin (Spain), X. Maldonado, J. Planas, M. Hermida,
M.J. Mañas, S. Mico, J. Morote, J. Giralt
PO-0744
> Significant correlation between prostate volume and obstructive voiding
symptom in hypofractionation
S. Pérez Echagüen (Spain), C.J. Sanz Freire, G.A. Ossola Lentati
PO-0745
> Spanish validation of Charlson Index applied to prostate cancer
F. Casas i Duran (Spain), F. Ferrer, A. Herreros, J. Saez, C. Camacho
PO-0746